世界の向精神薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04409)
◆英語タイトル:Global Psychotropic Pharmaceuticals Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04409
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは向精神薬の世界市場について調査・分析した資料です。種類別(抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬)の市場規模、用途別(病院薬局、ドラッグストア、小売店、Eコマース)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別向精神薬の競争状況、市場シェア
・世界の向精神薬市場:種類別市場規模 2015年-2020年(抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬)
・世界の向精神薬市場:種類別市場規模予測 2021年-2026年(抗うつ薬、抗精神病薬、覚醒剤、抗不安薬、気分安定薬)
・世界の向精神薬市場:用途別市場規模 2015年-2020年(病院薬局、ドラッグストア、小売店、Eコマース)
・世界の向精神薬市場:用途別市場規模予測 2021年-2026年(病院薬局、ドラッグストア、小売店、Eコマース)
・北米の向精神薬市場分析:米国、カナダ
・ヨーロッパの向精神薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの向精神薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の向精神薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの向精神薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Teva Pharmaceuticals、Novartis、Mylan、AstraZeneca、Sun Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Psychotropic pharmaceutical is a chemical substance that changes brain function and results in alterations in perception, mood, consciousness, cognition or behavior.
The global psychotropic pharmaceuticals market is expected to grow rapidly over the forecast period owing to the raising prevalence of mental disorders.

Market Analysis and Insights: Global Psychotropic Pharmaceuticals Market
The global Psychotropic Pharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Psychotropic Pharmaceuticals Scope and Market Size
Psychotropic Pharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psychotropic Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Teva Pharmaceuticals
Novartis
Mylan
AstraZeneca
Sun Pharmaceuticals

Market segment by Type, the product can be split into
Anti-Depressants
Anti-Psychotics
Stimulants
Anxiolytics
Mood Stabilizers
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psychotropic Pharmaceuticals Revenue
1.4 Market by Type
1.4.1 Global Psychotropic Pharmaceuticals Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-Depressants
1.4.3 Anti-Psychotics
1.4.4 Stimulants
1.4.5 Anxiolytics
1.4.6 Mood Stabilizers
1.5 Market by Application
1.5.1 Global Psychotropic Pharmaceuticals Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Psychotropic Pharmaceuticals Market Perspective (2015-2026)
2.2 Global Psychotropic Pharmaceuticals Growth Trends by Regions
2.2.1 Psychotropic Pharmaceuticals Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Psychotropic Pharmaceuticals Historic Market Share by Regions (2015-2020)
2.2.3 Psychotropic Pharmaceuticals Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Psychotropic Pharmaceuticals Market Growth Strategy
2.3.6 Primary Interviews with Key Psychotropic Pharmaceuticals Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Psychotropic Pharmaceuticals Players by Market Size
3.1.1 Global Top Psychotropic Pharmaceuticals Players by Revenue (2015-2020)
3.1.2 Global Psychotropic Pharmaceuticals Revenue Market Share by Players (2015-2020)
3.1.3 Global Psychotropic Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psychotropic Pharmaceuticals Market Concentration Ratio
3.2.1 Global Psychotropic Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Psychotropic Pharmaceuticals Revenue in 2019
3.3 Psychotropic Pharmaceuticals Key Players Head office and Area Served
3.4 Key Players Psychotropic Pharmaceuticals Product Solution and Service
3.5 Date of Enter into Psychotropic Pharmaceuticals Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Psychotropic Pharmaceuticals Historic Market Size by Type (2015-2020)
4.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Psychotropic Pharmaceuticals Market Size by Application (2015-2020)
5.2 Global Psychotropic Pharmaceuticals Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Psychotropic Pharmaceuticals Market Size (2015-2020)
6.2 Psychotropic Pharmaceuticals Key Players in North America (2019-2020)
6.3 North America Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
6.4 North America Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

7 Europe
7.1 Europe Psychotropic Pharmaceuticals Market Size (2015-2020)
7.2 Psychotropic Pharmaceuticals Key Players in Europe (2019-2020)
7.3 Europe Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
7.4 Europe Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

8 China
8.1 China Psychotropic Pharmaceuticals Market Size (2015-2020)
8.2 Psychotropic Pharmaceuticals Key Players in China (2019-2020)
8.3 China Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
8.4 China Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

9 Japan
9.1 Japan Psychotropic Pharmaceuticals Market Size (2015-2020)
9.2 Psychotropic Pharmaceuticals Key Players in Japan (2019-2020)
9.3 Japan Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
9.4 Japan Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Psychotropic Pharmaceuticals Market Size (2015-2020)
10.2 Psychotropic Pharmaceuticals Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
10.4 Southeast Asia Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

11 India
11.1 India Psychotropic Pharmaceuticals Market Size (2015-2020)
11.2 Psychotropic Pharmaceuticals Key Players in India (2019-2020)
11.3 India Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
11.4 India Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Psychotropic Pharmaceuticals Market Size (2015-2020)
12.2 Psychotropic Pharmaceuticals Key Players in Central & South America (2019-2020)
12.3 Central & South America Psychotropic Pharmaceuticals Market Size by Type (2015-2020)
12.4 Central & South America Psychotropic Pharmaceuticals Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Details
13.1.2 Teva Pharmaceuticals Business Overview
13.1.3 Teva Pharmaceuticals Psychotropic Pharmaceuticals Introduction
13.1.4 Teva Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020))
13.1.5 Teva Pharmaceuticals Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Psychotropic Pharmaceuticals Introduction
13.2.4 Novartis Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Psychotropic Pharmaceuticals Introduction
13.3.4 Mylan Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Psychotropic Pharmaceuticals Introduction
13.4.4 AstraZeneca Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Sun Pharmaceuticals
13.5.1 Sun Pharmaceuticals Company Details
13.5.2 Sun Pharmaceuticals Business Overview
13.5.3 Sun Pharmaceuticals Psychotropic Pharmaceuticals Introduction
13.5.4 Sun Pharmaceuticals Revenue in Psychotropic Pharmaceuticals Business (2015-2020)
13.5.5 Sun Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Teva Pharmaceuticals、Novartis、Mylan、AstraZeneca、Sun Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の向精神薬市場2026:インサイト・予測(Global Psychotropic Pharmaceuticals Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。